Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John E Harrison

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Alzheimer'S Disease : JAD|October 22, 2016
Effect Size Analyses of Souvenaid in Patients with Alzheimer's DiseaseJeffrey Cummings, Philip Scheltens, Ian McKeith, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 22, 2020
The Cognitive-Functional Composite is sensitive to clinical progression in early dementia: Longitudinal findings from the Catch-Cog study cohortRoos J Jutten, John E Harrison, A J Brunner, et al.
Neuropsychology|September 7, 2023
What's in a score: A longitudinal investigation of scores based on item response theory and classical test theory for the Amsterdam Instrumental Activities of Daily Living Questionnaire in cognitively normal and impaired older adultsMark A Dubbelman, Merel C Postema, Roos J Jutten, et al.
Alzheimer'S Research & Therapy|May 17, 2019
Assessing cognition and daily function in early dementia using the cognitive-functional composite: findings from the Catch-Cog study cohortRoos J Jutten, John E Harrison, Philippe R Lee Meeuw Kjoe, et al.
Alzheimer'S Research & Therapy|March 4, 2020
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's diseaseMartí Colom-Cadena, Tara Spires-Jones, Henrik Zetterberg, et al.
Journal of Medical Internet Research|May 27, 2025
Smartphone- and Tablet-Based Tools to Assess Cognition in Individuals With Preclinical Alzheimer Disease and Mild Cognitive Impairment: Scoping ReviewRosanne L van den Berg, Sophie M van der Landen, Matthijs J Keijzer, et al.
International Journal of Methods in Psychiatric Research|August 9, 2018
Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteersJohn E Harrison, Harry Barry, Bernhard T Baune, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersCasper de Boer, Rosanne L van den Berg, Marissa D Zwan, et al.
Neurology|January 2, 2024
Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined SubgroupsMark A Dubbelman, Heleen M A Hendriksen, John E Harrison, et al.
Nature Communications|September 21, 2022
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degenerationYing Jiang, John J Alam, Stephen N Gomperts, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Alzheimer'S Disease : JAD|October 22, 2016
Effect Size Analyses of Souvenaid in Patients with Alzheimer's DiseaseJeffrey Cummings, Philip Scheltens, Ian McKeith, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 22, 2020
The Cognitive-Functional Composite is sensitive to clinical progression in early dementia: Longitudinal findings from the Catch-Cog study cohortRoos J Jutten, John E Harrison, A J Brunner, et al.
Neuropsychology|September 7, 2023
What's in a score: A longitudinal investigation of scores based on item response theory and classical test theory for the Amsterdam Instrumental Activities of Daily Living Questionnaire in cognitively normal and impaired older adultsMark A Dubbelman, Merel C Postema, Roos J Jutten, et al.
Alzheimer'S Research & Therapy|May 17, 2019
Assessing cognition and daily function in early dementia using the cognitive-functional composite: findings from the Catch-Cog study cohortRoos J Jutten, John E Harrison, Philippe R Lee Meeuw Kjoe, et al.
Alzheimer'S Research & Therapy|March 4, 2020
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's diseaseMartí Colom-Cadena, Tara Spires-Jones, Henrik Zetterberg, et al.
Journal of Medical Internet Research|May 27, 2025
Smartphone- and Tablet-Based Tools to Assess Cognition in Individuals With Preclinical Alzheimer Disease and Mild Cognitive Impairment: Scoping ReviewRosanne L van den Berg, Sophie M van der Landen, Matthijs J Keijzer, et al.
International Journal of Methods in Psychiatric Research|August 9, 2018
Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteersJohn E Harrison, Harry Barry, Bernhard T Baune, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersCasper de Boer, Rosanne L van den Berg, Marissa D Zwan, et al.
Neurology|January 2, 2024
Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined SubgroupsMark A Dubbelman, Heleen M A Hendriksen, John E Harrison, et al.
Nature Communications|September 21, 2022
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degenerationYing Jiang, John J Alam, Stephen N Gomperts, et al.
Pageof 4